Replimune Group, Inc. Contracts & Agreements
71 Contracts & Agreements
- Business Finance (28 contracts)
- Business Operations (2)
- Human Resources (30)
- Real Estate (3)
- Uncategorized (8)
- Form of Pre-Funded Warrant (Filed With SEC on December 4, 2024)
- Underwriting Agreement dated November 25, 2024 (Filed With SEC on November 27, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on November 27, 2024)
- Form of U.K. Inducement Restricted Stock Unit Grant Agreement (Filed With SEC on November 12, 2024)
- Form of U.K. Inducement Stock Option Grant Agreement (Filed With SEC on November 12, 2024)
- Executive Severance Plan for Chief-Level Executives (Filed With SEC on November 12, 2024)
- Form of Registration Rights Agreement (Filed With SEC on June 13, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on June 13, 2024)
- Securities Purchase Agreement, dated June 12, 2024, by and among Replimune Group, Inc. and each of the investors as party thereto (Filed With SEC on June 13, 2024)
- Replimune Group, Inc. Clawback Policy (Filed With SEC on May 16, 2024)
- Separation Agreement and Release, dated as of March 26, 2024, by and between Pamela Esposito and Replimune, Inc (Filed With SEC on May 16, 2024)
- Consulting Agreement, dated as of March 25, 2024, by and between Robert Coffin and Replimune, Inc (Filed With SEC on May 16, 2024)
- Separation and Transition Agreement, dated as of March 25, 2024, by and between Robert Coffin and Replimune, Inc (Filed With SEC on May 16, 2024)
- Second Amended and Restated Employment Agreement, dated as of March 25, 2024, by and between Replimune, Inc. and Philip Astley-Sparke (Filed With SEC on May 16, 2024)
- Second Amended and Restated Employment Agreement, dated as of March 25, 2024, by and between Replimune, Inc. and Sushil Patel (Filed With SEC on May 16, 2024)
- Form of Inducement Restricted Stock Unit Grant Agreement (Filed With SEC on May 16, 2024)
- Form of Inducement Stock Option Grant Agreement (Filed With SEC on May 16, 2024)
- Form of Performance Stock Unit Award Agreement under 2018 Omnibus Incentive Compensation Plan and Sub-Plan for U.K. Employees (Filed With SEC on May 16, 2024)
- Form of Performance Stock Unit Award Agreement under 2018 Omnibus Incentive Compensation Plan (Filed With SEC on May 16, 2024)
- Description of the Registrants Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on May 16, 2024)
- Consulting Agreement, dated as of March 26, 2024, by and between Pamela Esposito and Replimune, Inc (Filed With SEC on May 16, 2024)
- Separation Agreement and Release, dated as of March 31, 2024, by and between Tanya Lewis and Replimune, Inc (Filed With SEC on May 16, 2024)
- Consulting Agreement, dated as of March 31, 2024, by and between Tanya Lewis and Replimune, Inc (Filed With SEC on May 16, 2024)
- Second Amendment to Loan and Security Agreement, dated as of December 22, 2023, by and among Replimune Group Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc (Filed With SEC on February 8, 2024)
- Stock Option Grant Agreement, effective as of (Filed With SEC on November 7, 2023)
- Employment Agreement, dated as of (Filed With SEC on November 7, 2023)
- Restricted Stock Unit (Filed With SEC on November 7, 2023)
- Amended to Employment Agreement, dated as of September 20, 2023, by and between Pamela Esposito and Replimune, Inc (Filed With SEC on November 7, 2023)
- Consulting Agreement, dated as of May 18, 2023 by and between Jean Franchi and Replimune, Inc (Filed With SEC on August 3, 2023)
- Separation Agreement and Release, dated as of May 18, 2023 by and between Jean Franchi and Replimune, Inc (Filed With SEC on August 3, 2023)
- First Amendment to (Filed With SEC on August 3, 2023)
- Lease Agreement, dated as of (Filed With SEC on May 18, 2023)
- Description of the Registrants Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on May 18, 2023)
- Stock Option Grant Agreement, effective as of December 30, 2022, by and between Christopher Sarchi and the Registrant (Filed With SEC on May 18, 2023)
- Restricted Stock Unit Grant Agreement, effective as of December 30, 2022, by and between Christopher Sarchi and the Registrant (Filed With SEC on May 18, 2023)
- Employment Agreement, dated as of December 1, 2022, by and between Konstantinos Xynos and Replimune, Inc (Filed With SEC on February 9, 2023)
- Amendment to Amended and Restated Employment Agreement, dated as of December 30, 2022, by and between Sushil Patel and Replimune, Inc (Filed With SEC on February 9, 2023)
- Employment Agreement, dated as of December 30, 2022, by and between Christopher Sarchi and Replimune, Inc (Filed With SEC on February 9, 2023)
- Underwriting Agreement dated December 8, 2022 (Filed With SEC on December 12, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on December 12, 2022)
- Description of the Registrants Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on May 19, 2022)
- 2018 Omnibus Incentive Compensation Plan and Sub-Plan for U.K. Employees and forms of agreements thereunder (Filed With SEC on May 19, 2022)
- Separation Agreement and Release, dated as of August 25, 2021, by and between Andrea Pirzkall and Replimune, Inc., as amended (Filed With SEC on May 19, 2022)
- Lease Agreement, dated October 29, 2021, by and among Replimune Limited, MEPC Milton Park No. 1 Limited, and MEPC Milton Park No. 2 Limited (Filed With SEC on February 3, 2022)
- Amended and Restated Employment Agreement, dated as of November 2, 2021, by and between Philip Astley-Sparke and Replimune, Inc (Filed With SEC on November 4, 2021)
- Amended and Restated Employment Agreement, dated as of November 2, 2021, by and between Robert Coffin and Replimune, Inc (Filed With SEC on November 4, 2021)
- Employment Agreement, dated as of May 10, 2021, by and between Tanya Lewis and Replimune, Inc (Filed With SEC on May 20, 2021)
- Stock Option Grant Agreement, effective as of May 3, 2021, by and between Sushil Patel and the Registrant (Filed With SEC on May 20, 2021)
- Amended and Restated Employment Agreement, dated as of May 3, 2021, by and between Sushil Patel and Replimune, Inc (Filed With SEC on May 20, 2021)
- Description of the Registrants Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on May 20, 2021)
- Restricted Stock Unit Grant Agreement, effective as of May 3, 2021, by and between Sushil Patel and the Registrant (Filed With SEC on May 20, 2021)
- Payoff Letter to Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated December 15, 2020 (Filed With SEC on February 4, 2021)
- Underwriting Agreement dated October 21, 2020 (Filed With SEC on October 23, 2020)
- Deed of Variation, dated June 29, 2020, by and among MEPC Milton Park No. 1 Limited and MEPC Milton Park No. 2 Limited, and Replimune Limited (Filed With SEC on August 7, 2020)
- Employment Agreement, dated May 25, 2020, by and between Replimune Inc. and Andrea Pirzkall (Filed With SEC on August 7, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on June 10, 2020)
- Underwriting Agreement dated June 8, 2020 (Filed With SEC on June 10, 2020)
- First Amendment to Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated June 1, 2020 (Filed With SEC on June 3, 2020)
- Description of the Registrant's Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on June 3, 2020)
- Clinical Trial Collaboration and Supply Agreement (RP-2), dated April 12, 2019, by and between Bristol-Myers Squibb Company and Replimune, Inc (Filed With SEC on June 3, 2020)
- Separation Agreement and Release, dated as of March 30, 2020, by and between Stephen Gorgol and Replimune, Inc (Filed With SEC on June 3, 2020)
- Separation Agreement and Release, dated December 23, 2019, by and between Replimune Inc. and Howard Kaufman (Filed With SEC on February 13, 2020)
- Employment Agreement, dated November 27, 2019 (Filed With SEC on December 9, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on November 18, 2019)
- Underwriting Agreement dated November 14, 2019 (Filed With SEC on November 18, 2019)
- Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated August 7, 2019 (Filed With SEC on August 8, 2019)
- Employment Agreement, dated as of May 8, 2019, by and between Stephen Gorgol and Replimune, Inc (Filed With SEC on June 28, 2019)
- Description of Capital Stock (Filed With SEC on June 28, 2019)
- Lease, dated as of June 7, 2019, by and between Replimune Group, Inc. and ND/CR Unicorn LLC (Filed With SEC on June 13, 2019)
- Master Clinical Trial Collaboration and Supply Agreement, dated as of May 29, 2018, by and between Regeneron Pharmaceuticals, Inc. and the Registrant (Filed With SEC on July 17, 2018)
- 2017 Equity Compensation Plan and Sub-Plan for UK Employees and forms of agreements thereunder (Filed With SEC on June 26, 2018)
